Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,588 | 37,981 | 44,735 | 80,743 | 73,441 |
| Marketable Securities | 49,466 | 50,598 | 43,644 | N/A | N/A |
| Receivables | 54,120 | 44,944 | 39,913 | 42,610 | 47,663 |
| Inventories | 38,308 | 39,788 | 39,080 | 38,602 | 37,686 |
| TOTAL | $202,549 | $181,156 | $177,852 | $172,474 | $171,062 |
| Non-Current Assets | |||||
| PPE Net | 586 | 624 | 664 | 704 | 770 |
| Intangibles | 80,471 | 92,359 | 99,030 | 105,701 | 111,332 |
| Other Non-Current Assets | 1,126 | 1,860 | 1,897 | 3,086 | 3,255 |
| TOTAL | $82,183 | $94,843 | $101,591 | $109,491 | $115,357 |
| Total Assets | $284,732 | $275,999 | $279,443 | $281,965 | $286,419 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,736 | 13,153 | 15,271 | 15,650 | 13,439 |
| Accrued Expenses | 95,151 | 73,446 | 73,548 | 73,271 | 76,350 |
| Other current liabilities | 4,801 | 3,505 | 3,365 | 3,523 | 3,654 |
| TOTAL | $114,688 | $90,104 | $92,184 | $92,444 | $93,443 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,813 | 38,840 | 38,729 | 38,621 | 38,514 |
| Other Non-Current Liabilities | 10,150 | 16,537 | 16,377 | 16,406 | 16,459 |
| TOTAL | $48,963 | $55,377 | $55,106 | $55,027 | $54,973 |
| Total Liabilities | $163,651 | $145,481 | $147,290 | $147,471 | $148,416 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,388 | 6,368 | 6,359 | 6,345 | 6,336 |
| Common Shares | 1 | 9 | 9 | 9 | 9 |
| Retained earnings | -673,124 | -662,648 | -659,727 | -656,053 | -651,543 |
| TOTAL | $121,081 | $130,518 | $132,153 | $134,494 | $138,003 |
| Total Liabilities And Equity | $284,732 | $275,999 | $279,443 | $281,965 | $286,419 |